📅 23 August 2025
DOI: 10.26877/asset.v7i3.1872
Association Between PAI-1 4G/5G Genetic Polymorphism and Uncontrolled Allergic Asthma
Advance Sustainable Science, Engineering and Technology (ASSET)
Universitas Persatuan Guru Republik Indonesia Semarang
📄 Abstract
Airway remodeling is a major challenge in the management of uncontrolled allergic asthma, despite standard therapy with a combination of inhaled corticosteroids (ICS) and long-acting bronchodilators (LABA). Increased levels of Plasminogen Activator Inhibitor-1 (PAI-1) are thought to play a role in this process, and the 4G/5G polymorphism in the PAI-1 gene is one of the genetic factors that affect it. This study aimed to analyze the association between the 4G/5G PAI-1 genetic polymorphism and uncontrolled allergic asthma. A case-control study was conducted at Wahidin Sudirohusodo General Hospital between January-March 2024 on 40 patients with allergic asthma and 40 non-asthmatic subjects. Diagnosis was made through prik test (+), bronchodilator test (+), and asthma control classification according to GINA criteria. All asthmatic patients received Budesonide-Formoterol therapy for 4 weeks. PAI-1 levels were measured and 4G/5G polymorphism was analyzed by RT-PCR. Results showed that PAI-1 levels were significantly higher in uncontrolled asthma patients and in individuals with the 4G/4G genotype compared to non-4G/4G (2.38 ± 0.770 vs 1.65 ± 0.714; p=0.001). The 4G/4G genotype was more common in uncontrolled asthma (OR: 5.8) and was associated with the risk of severe obstruction (OR: 11.6). Thus, it was concluded that the 4G/4G genotype in the PAI-1 gene is associated with increased PAI-1 levels, risk of uncontrolled allergic asthma, and more severe degree of airway obstruction. The implication of the results shows that genetic testing of PAI-1 has the potential to be a predictive biomarker in personalized asthma therapy strategies. This approach can help clinicians identify high-risk patients and tailor interventions early and effectively to prevent remodeling and reduce long-term morbidity.
🔖 Keywords
#allergic asthma; 4G/5G PAI-1 polymorphism; genetic polymorphism; plasminogen activator inhibitor-1; asthma control
ℹ️ Informasi Publikasi
Tanggal Publikasi
23 August 2025
Volume / Nomor / Tahun
Volume 7, Nomor 3, Tahun 2025
📝 HOW TO CITE
Iskandar, Harun; Ilyas, Muh; Muis, Eliana; Tabri, Nur Ahmad; Setiawati, Dewi, "Association Between PAI-1 4G/5G Genetic Polymorphism and Uncontrolled Allergic Asthma," Advance Sustainable Science, Engineering and Technology (ASSET), vol. 7, no. 3, Aug. 2025.
ACM
ACS
APA
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Download Citation
0
Sitasi
Cek Google Scholar